Patents by Inventor Ying-Hong Feng

Ying-Hong Feng has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Truncated proteins as cancer markers
    Patent number: 8518652
    Abstract: Methods/reagents for detecting and/or treating cancers or potential cancers are disclosed. In one embodiment, methods and reagents for detecting truncated forms of P2X7 protein in cells are described. In one embodiment, methods and reagents for increasing the amount and/or activity of full-length P2X7 in cells are described. In one embodiment, methods and reagents for decreasing the amount and/or activity of truncated P2X7 in cells are described.
    Type: Grant
    Filed: April 28, 2010
    Date of Patent: August 27, 2013
    Assignees: Uniformed Services University of the Health Sciences, an Institution of Higher Learning within the Department of Defense., The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.
    Inventors: George Gorodeski, Ying-Hong Feng, Xin Li
  • Truncated Proteins As Cancer Markers
    Publication number: 20100273182
    Abstract: Methods/reagents for detecting and/or treating cancers or potential cancers are disclosed. In one embodiment, methods and reagents for detecting truncated forms of P2X7 protein in cells are described. In one embodiment, methods and reagents for increasing the amount and/or activity of full-length P2X7 in cells are described. In one embodiment, methods and reagents for decreasing the amount and/or activity of truncated P2X7 in cells are described.
    Type: Application
    Filed: April 28, 2010
    Publication date: October 28, 2010
    Inventors: George Gorodeski, Ying-Hong Feng, Xin Li
  • Truncated proteins as cancer markers
    Patent number: 7767789
    Abstract: Methods/reagents for detecting and/or treating cancers or potential cancers are disclosed. In one embodiment, methods and reagents for detecting truncated forms of P2X7 protein in cells are described. In one embodiment, methods and reagents for increasing the amount and/or activity of full-length P2X7 in cells are described. In one embodiment, methods and reagents for decreasing the amount and/or activity of truncated P2X7 in cells are described.
    Type: Grant
    Filed: June 2, 2006
    Date of Patent: August 3, 2010
    Assignees: University Hopitals of Cleveland, The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.
    Inventors: George Gorodeski, Ying-Hong Feng, Xin Li
  • Truncated proteins as cancer markers
    Publication number: 20070020706
    Abstract: Methods/reagents for detecting and/or treating cancers or potential cancers are disclosed. In one embodiment, methods and reagents for detecting truncated forms of P2X7 protein in cells are described. In one embodiment, methods and reagents for increasing the amount and/or activity of full-length P2X7 in cells are described. In one embodiment, methods and reagents for decreasing the amount and/or activity of truncated P2X7 in cells are described.
    Type: Application
    Filed: June 2, 2006
    Publication date: January 25, 2007
    Inventors: George Gorodeski, Ying-Hong Feng, Xin Li